VOYA Investment Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Buy |
+26,879
| New | +$38.2K | ﹤0.01% | 2631 |
|
|
2023
Q4 | – | Sell |
-28,525
| Closed | -$195K | – | 2898 |
|
|
2023
Q3 | $195K | Buy |
28,525
+684
| +2% | +$4.69K | ﹤0.01% | 2559 |
|
|
2023
Q2 | $289K | Sell |
27,841
-78,915
| -74% | -$818K | ﹤0.01% | 2387 |
|
|
2023
Q1 | $864K | Hold |
106,756
| – | – | ﹤0.01% | 1738 |
|
|
2022
Q4 | $1.68M | Hold |
106,756
| – | – | ﹤0.01% | 1401 |
|
|
2022
Q3 | $1.68M | Buy |
106,756
+84,287
| +375% | +$1.33M | ﹤0.01% | 1394 |
|
|
2022
Q2 | $314K | Buy |
22,469
+2,461
| +12% | +$34.4K | ﹤0.01% | 2144 |
|
|
2022
Q1 | $345K | Hold |
20,008
| – | – | ﹤0.01% | 2113 |
|
|
2021
Q4 | $291K | Buy |
20,008
+265
| +1% | +$3.85K | ﹤0.01% | 2318 |
|
|
2021
Q3 | $355K | Buy |
19,743
+2,601
| +15% | +$46.8K | ﹤0.01% | 2246 |
|
|
2021
Q2 | $301K | Buy |
+17,142
| New | +$301K | ﹤0.01% | 2376 |
|
|
2020
Q2 | – | Sell |
-16,490
| Closed | -$17K | – | 2504 |
|
|
2020
Q1 | $17K | Hold |
16,490
| – | – | ﹤0.01% | 2596 |
|
|
2019
Q4 | $31K | Buy |
16,490
+2,303
| +16% | +$4.33K | ﹤0.01% | 2663 |
|
|
2019
Q3 | $15K | Hold |
14,187
| – | – | ﹤0.01% | 2547 |
|
|
2019
Q2 | $31K | Hold |
14,187
| – | – | ﹤0.01% | 2576 |
|
|
2019
Q1 | $85K | Hold |
14,187
| – | – | ﹤0.01% | 2453 |
|
|
2018
Q4 | $105K | Buy |
14,187
+2,846
| +25% | +$21.1K | ﹤0.01% | 2391 |
|
|
2018
Q3 | $165K | Hold |
11,341
| – | – | ﹤0.01% | 2395 |
|
|
2018
Q2 | $226K | Buy |
+11,341
| New | +$226K | ﹤0.01% | 2308 |
|
|
2018
Q1 | – | Sell |
-9,852
| Closed | -$243K | – | 2580 |
|
|
2017
Q4 | $243K | Hold |
9,852
| – | – | ﹤0.01% | 2247 |
|
|
2017
Q3 | $254K | Buy |
9,852
+762
| +8% | +$19.6K | ﹤0.01% | 2252 |
|
|
2017
Q2 | $247K | Buy |
+9,090
| New | +$247K | ﹤0.01% | 2286 |
|